Literature DB >> 12615884

In vitro activity of fluoroquinolones against erythromycin-susceptible and -resistant Bordetella pertussis.

Nadege Bourgeois, Jean-Claude Ghnassia, Florence Doucet-Populaire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12615884     DOI： 10.1093/jac/dkg145

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Emergence of quinolone-resistant Bordetella pertussis in Japan.

Authors:  Masayuki Ohtsuka; Ken Kikuchi; Kenichiro Shimizu; Namiko Takahashi; Yuka Ono; Takashi Sasaki; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

2.  Selection of Pneumococci.

Authors:  Pramod M Shah
Journal:  Dtsch Arztebl Int       Date:  2009-01-23       Impact factor: 5.594

3.  Abundance of the nasopharyngeal microbiome effects pertussis diagnosis and explains the sensitivity difference between bacterial culture and real-time PCR.

Authors:  Yijun Ding; Qing Wang; Dongfang Li; Kaihu Yao; Tianyou Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-03       Impact factor: 3.267

4.  The BvgAS signal transduction system regulates biofilm development in Bordetella.

Authors:  Meenu Mishra; Gina Parise; Kara D Jackson; Daniel J Wozniak; Rajendar Deora
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.